Komori
Kringle Pharma (4884) · InitiativeAdvanced

Expanding Human Capital and Establishing Flexible Work and Training Programs

First written in FY2023. 5 of 6 entries say "Advanced", first in FY2024-Q2. Latest entry: 2026-06-26.

6entries
4years
3from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2023AdvancedFY2024-Q2 – 2026-06-262023: 12024: 120242025: 120252026: 32026
Same theme, other companies

108 other companies' latest entry also says "Advanced".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 196 companies compared. The sentences above are computed from all 196.Comparing 200 of the theme's 246 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2025-H1AdvancedAnnual report

    「第15回新株予約権 決議年月日 2024年11月20日 付与対象者の区分及び人数 当社従業員13名 新株予約権の目的となる株式の種類、内容及び数(株) 普通株式 30,000 新株予約権の行使期間 2026年11月21日~2034年11月20日」

    従業員13名を対象に最大30,000株の第15回新株予約権を付与し、人的資本施策としてのストックオプションを具体化した。
  2. FY2024-Q2AdvancedAnnual report

    「第14回新株予約権 付与対象者の区分及び人数 当社従業員4名 新株予約権の目的となる株式の種類、内容及び数(株)※ 普通株式 46,000 新株予約権の行使期間※ 2026年2月15日~ 2034年2月14日」

    2024年2月14日に、従業員4名を対象として最大46,000株の第14回新株予約権を付与した。人的資本施策として記載されていたストックオプション制度が具体的な付与段階に進んだ。
  3. FY2023First statedAnnual report

    「Specifically, we have introduced a fully flexible working-hours system, established a remote-work structure based on digitalization to achieve work-life balance and improve employee productivity, and implemented various systems to secure human resources, including stock option programs, as well as employee training that takes advantage of opportunities inside and outside the company.」

    The company has implemented fully flexible working hours, remote work, stock options and employee training to secure personnel and improve productivity.
Moved together

"Monetization Through International Sales Expansion and API Supply" moved the same way as this thread, in the same document, in 2 of its 6 moves.

22★12
  1. ★This thread
  2. 1Monetization Through International Sales Expansion and API Supply2×
  3. 2Completion of the Phase III Clinical Trial for KP-100IT and Submission of the Application for Marketing Approval2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Kringle Pharma yet. It last moved in the Share Issuance and Disposal of 2026-06-26: "Advanced".
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.